The Stanford team was retained (paid) by a Canadian company that has a proprietary formulation of NAC. (That means they own patent rights and can charge royalties and license fees. NAC in your local health food store is cheap as dirt. This stuff isn't, because of the patent.) If this formulation of NAC becomes prescribed by the CF Clinics of the USA and Canada, then the company, the CFF (who helped arrange the trial), and possibly Stanford will all get a cut on each sale.

One of the first lessons in the CF world that caused me great grief was, "follow the money." It should be "follow the cure even if it doesn't make money," but that isn't how the world works.

But, as I have repeatedly said, my family uses both GSH and NAC. But we use much more GSH than NAC. We would consider giving GSH without NAC, but we would not consider giving NAC without GSH. And because of sheer frustration and revolt at a medical system gone haywire, we would only buy our NAC from our local health food store, not from this Canadian company.